Trapidil structure
|
Common Name | Trapidil | ||
---|---|---|---|---|
CAS Number | 15421-84-8 | Molecular Weight | 205.260 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C10H15N5 | Melting Point | 98-99.4° (Pfeifer); 102-104° from heptane (Tenor) | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of TrapidilTrapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor. |
Name | N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
---|---|
Synonym | More Synonyms |
Description | Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor. |
---|---|
Related Catalog |
Density | 1.2±0.1 g/cm3 |
---|---|
Melting Point | 98-99.4° (Pfeifer); 102-104° from heptane (Tenor) |
Molecular Formula | C10H15N5 |
Molecular Weight | 205.260 |
Exact Mass | 205.132751 |
PSA | 46.32000 |
LogP | 1.45 |
Index of Refraction | 1.626 |
Storage condition | room temp |
Water Solubility | H2O: ≥15mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36/37/38 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
HS Code | 2933990090 |
~% Trapidil CAS#:15421-84-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 6, p. 583,585 |
~% Trapidil CAS#:15421-84-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 6, p. 583,585 |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Protective effects of trapidil in ischemia-reperfusion injury due to testicular torsion and detorsion: an experimental study.
Int. J. Urol. 13(5) , 601-5, (2006) We aimed to detect the preventive effects of trapidil in ischemia-reperfusion (IR) injury due to testicular torsion and detorsion.Forty prepubertal albino rats were used. In the IR group, torsion was ... |
|
Effects of trapidil on renal ischemia-reperfusion injury.
J. Pediatr. Surg. 41(10) , 1686-93, (2006) There is increasing evidence to suggest that reactive oxygen and nitrogen species play a role in the pathogenesis of renal ischemia-reperfusion (I/R) injury. This study was designed to determine the p... |
|
Clinical evidence for Japanese population based on prospective studies—Linking clinical trials and clinical practice
J. Cardiol. 54(2) , 171-82, (2009) “Evidence-based medicine (EBM)” implies effective and high quality practice for patients based on well-grounded medical science. The success of clinical trials in Japan is essential to build original ... |
Trapidil |
EINECS 239-434-2 |
(1,2,4)Triazolo(1,5-a)pyrimidin-7-amine,N,N-diethyl-5-methyl |
Rocornal |
5-methyl-7-diethylamino-s-triazolo[1,5-a]pyrimidine |
AR 12008,Avantrin,N,N-diethyl-5-methyl-[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine |
7-Diethylamino-5-methyl-s-triazolo[1,5-a]pyrimidine |
N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
N,N-dimethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
diethyl-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine |
Trapidilum [INN-Latin] |
Diaethyl-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amin |
Trapymin |
UNII:EYG5Y6355E |
[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine, N,N-diethyl-5-methyl- |
5-Methyl-7-diaethylamino-s-triazolo<1.5-a>pyrimidin |
N,N-Diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |